Kamran Hosseini | Biochemistry | Best Researcher Award

Best Researcher Award

Kamran Hosseini
Affiliation Shiraz University of Medical Sciences
Country Iran
Scopus ID 57226155096
Documents 32
Citations 638
h-index 10
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards
ORCID 0000-0003-1189-7143

Kamran Hosseini
Shiraz University of Medical Sciences, Iran

The Best Researcher Award recognizes distinguished scholars whose sustained scientific achievements, publication record, research quality, and academic influence demonstrate excellence within their respective disciplines. Kamran Hosseini has established an active research profile in biochemistry, genetics, molecular biology, neuroscience, and clinical medicine through peer-reviewed publications addressing neurological disorders, molecular signaling pathways, spinal surgery, and translational biomedical research.[1] His scholarly output, citation impact, and international visibility provide evidence of continued contributions to medical science and interdisciplinary biomedical research.[2]

Abstract

Kamran Hosseini has contributed to contemporary biomedical research through investigations spanning molecular biology, neurology, neurosurgery, gene therapy, spinal disorders, and translational medicine. His publication portfolio demonstrates interdisciplinary collaboration while integrating laboratory discoveries with clinical applications. Current research includes viral vector-mediated therapeutic strategies, spinal surgery outcomes, neurological disease mechanisms, and complex neurosurgical case management.[3] Such work reflects sustained engagement with evidence-based medicine and translational biomedical science.

Keywords

Best Researcher Award, Kamran Hosseini, Neuroscience, Molecular Biology, Gene Therapy, AAV Vectors, Biochemistry, Genetics, Neurosurgery, Clinical Research, Biomedical Science, Translational Medicine, Shiraz University of Medical Sciences.

Introduction

Recognition through a Best Researcher Award is commonly based upon sustained scholarly productivity, measurable research impact, publication quality, interdisciplinary collaboration, and contributions to scientific advancement. Researchers working across molecular biology and clinical medicine play an important role in translating laboratory discoveries into practical healthcare improvements.[1] Kamran Hosseini’s research activities illustrate this translational approach by integrating basic biological science with clinical neurosurgical investigations.

Research Profile

  • Affiliation: Shiraz University of Medical Sciences
  • Primary discipline: Biochemistry, Genetics and Molecular Biology
  • Scopus documents: 32
  • Total citations: 638
  • Scopus h-index: 10
  • Research interests include neuroscience, molecular signaling pathways, neurosurgery, spinal disorders, translational medicine, and gene therapy.

Research Contributions

The research portfolio demonstrates contributions across molecular neuroscience, neurological disorders, spinal surgery, and clinical case studies. Recent investigations evaluate adeno-associated virus (AAV) vectors for therapeutic modulation of cellular signaling pathways, assess perioperative interventions to reduce blood loss during spinal fusion procedures, and document rare neurosurgical cases that contribute to evidence-based clinical decision making.[3] These publications illustrate interdisciplinary collaboration between molecular biology and clinical neuroscience while supporting translational healthcare research.

Publications

  • AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders, Cell Biochemistry and Function (2026). DOI: 10.1002/cbf.70270.
  • Prophylactic effects of tranexamic acid in spinal fusion, Egyptian Journal of Neurosurgery (2026). DOI: 10.1186/s41984-026-00560-8.
  • Giant Lumbosacral Meningioma Without Dural Attachment in an Adolescent, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578462.
  • Management of Intrathoracic Huge Meningocele in Neurofibromatosis Type-1, International Medical Case Reports Journal (2026). DOI: 10.2147/IMCRJ.S578419.
  • Kümmell’s Disease in Benign Vertebral Compression Fractures, Clinical Neurology and Neurosurgery (2026). DOI: 10.1016/j.clineuro.2025.109262.

Research Impact

Available bibliometric indicators demonstrate an established publication record comprising 32 indexed documents, 638 citations, and an h-index of 10. These metrics indicate continued scholarly engagement and measurable scientific visibility within biomedical research.[1] The combination of molecular biology, neuroscience, and clinical investigations contributes to interdisciplinary knowledge relevant to both research laboratories and healthcare practice.

Award Suitability

Based on the available academic profile, publication activity, citation performance, interdisciplinary research scope, and contributions to peer-reviewed biomedical literature, Kamran Hosseini demonstrates characteristics commonly evaluated for academic recognition programs such as the Best Researcher Award. His research integrates molecular science with clinical application while contributing to neurological disease research, spinal surgery, and translational medicine through internationally published scientific work.[2]

Conclusion

Kamran Hosseini’s scholarly record reflects sustained participation in biomedical research characterized by interdisciplinary collaboration, clinically relevant investigations, and measurable academic impact. His publication portfolio, citation metrics, and recent contributions to neuroscience and molecular biology illustrate a research trajectory aligned with internationally recognized standards of scientific excellence and make his profile appropriate for consideration within academic recognition initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Kamran Hosseini, Author ID 57226155096. Scopus.
    https://www.scopus.com/pages/authors/57226155096
  2. ORCID. (n.d.). Kamran Hosseini ORCID Record.
    https://orcid.org/0000-0003-1189-7143
  3. Hosseini K. et al. (2026). AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies. Cell Biochemistry and Function. DOI: https://doi.org/10.1002/cbf.70270
  4. Hosseini K. et al. (2026). Prophylactic effects of tranexamic acid in spinal fusion. Egyptian Journal of Neurosurgery. https://doi.org/10.1186/s41984-026-00560-8
  5. Recent peer-reviewed publications in International Medical Case Reports Journal and Clinical Neurology and Neurosurgery (2026). https://doi.org/10.2147/IMCRJ.S578462

Joseph Adebayo | Biochemistry | Best Researcher Award

Prof Joseph Adebayo | Biochemistry | Best Researcher Award

Prof Joseph Adebayo, University of Ilorin, Nigeria

Professor Oluwatosin Adekunle Adaramoye, born on August 24, 1969, is a distinguished academic in the Department of Biochemistry, Faculty of Basic Medical Sciences at the University of Ibadan, Nigeria. He earned his Ph.D. in Biochemistry in 2005 from the University of Ibadan, following his M.Sc. in 1997 and B.Sc. in 1994. His career began as an Assistant Lecturer in 1998, and he was promoted to Professor in 2015. Professor Adaramoye’s research focuses on biochemical and pharmacological properties of medicinal plants, particularly in drug metabolism and cancer prevention. He has held significant administrative roles, including Head of Department and Provost. His global academic contributions are supported by numerous international fellowships and grants.

Publication Profile

Google Scholar

Strengths for the Award

  1. Extensive Research Experience:
    • Professor Adaramoye has an impressive array of research topics ranging from biochemistry of natural products to anti-cancer and anti-diabetic studies. This breadth and depth in research demonstrate a strong and sustained contribution to the field.
  2. Significant Grants and Fellowships:
    • Secured multiple prestigious grants and fellowships from notable institutions such as TWAS, UNESCO, and DAAD, indicating recognition by the global research community.
  3. High-Quality Publications:
    • Authored or co-authored numerous articles in reputable journals, which underscores a high level of scholarly output. For instance, papers in journals like Journal of Ethnopharmacology and Scientific Reports highlight significant contributions to medicinal plant research and pharmacology.
  4. Innovative Research Projects:
    • Ongoing projects such as the high throughput screening of Nigerian herbs for soluble epoxide hydrolase inhibition show innovative approaches to tackling critical health issues like hypertension and cardiovascular diseases.
  5. International Research Collaboration:
    • Extensive international collaborations with institutions in UAE, Brazil, Iran, Germany, and India suggest a strong global network and recognition in the field.
  6. Leadership and Administrative Roles:
    • Experience as Head of Department and other administrative roles indicates leadership and a significant role in shaping academic programs and research directions.

Areas for Improvement

  1. Publication Impact:
    • While the CV lists numerous publications, it would be beneficial to provide metrics such as impact factors or citation indices to better gauge the influence of the research work.
  2. Research Translation:
    • Focus on translating research findings into practical applications or products could be emphasized. Demonstrating how the research has led to tangible benefits or advancements in the field might strengthen the award application.
  3. Broader Interdisciplinary Work:
    • Exploring interdisciplinary research could further enhance the impact. For example, integrating biochemistry with fields like bioinformatics or computational biology might open new avenues for exploration.
  4. Mentorship and Training:
    • Highlighting efforts in mentoring and training young researchers or students, beyond the current supervision details, could provide a fuller picture of the professor’s contributions to the academic community.

Education

Professor Adaramoye’s educational journey includes a Bachelor of Science in Biochemistry from the University of Ilorin (1994), a Master of Science in Biochemistry from the University of Ibadan (1997), and a Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Ibadan (2005). His academic pursuits have been marked by a commitment to advancing knowledge in biochemistry through rigorous research and teaching. His doctoral thesis explored the biochemical and pharmacological properties of Garcinia kola, highlighting his focus on natural products and their therapeutic potentials.

Experience

With over two decades of academic experience, Professor Adaramoye has served as Assistant Lecturer, Lecturer, Senior Lecturer, Reader, and Professor of Biochemistry at the University of Ibadan. His teaching spans undergraduate and postgraduate levels, including courses in Enzymology, Lipid Biochemistry, and Drug Metabolism. He has supervised numerous research projects for B.Sc., M.Sc., and Ph.D. students. His administrative roles include Head of Department and Provost, demonstrating his leadership in academic governance and curriculum development.

Awards and Honors

Professor Adaramoye has received several prestigious awards and honors throughout his career. Notable recognitions include the University of Ilorin Undergraduate Scholarship Award, Federal Government of Nigeria Scholarship for Postgraduate Studies, and multiple international travel grants for scientific meetings. His post-doctoral fellowships and visiting scientist positions at institutions in Brazil, Iran, Germany, and India underscore his global impact and collaboration in biochemistry research. His work has been further supported by TETFUND and various other grants for research on medicinal plants.

Research Focus

Professor Adaramoye’s research focuses on the biochemical and pharmacological properties of medicinal plants, with particular interest in their potential as therapeutic agents. His work includes evaluating anti-oxidative, anti-diabetic, and anti-cancer effects of plant extracts. Current research involves screening Nigerian herbs for their potential as soluble epoxide hydrolase inhibitors, targeting hypertension and cardiovascular diseases. His studies aim to discover novel, less toxic natural products for drug development and therapeutic applications.

Publication Top Notes

  • Potential antimalarials from Nigerian plants: a review 🌿
  • Effect of ethanolic extract of Bougainvillea spectabilis leaves on haematological and serum lipid variables in rats 🩸
  • Proximate composition and phytochemical constituents of leaves of some Acalypha species 🍃
  • Testing of natural products and synthetic molecules aiming at new antimalarials 💊
  • Effect of ethanolic extract of Khaya senegalensis on some biochemical parameters of rat kidney 🧬
  • Effects of aqueous extract of Eucalyptus globulus on lipid peroxidation and selected enzymes of rat liver 🌳
  • Enhancing the antimalarial activity of artesunate 💉
  • Effects of Aqueous Extracts of Petals of Red and Green Hibiscus sabdariffa on Plasma Lipid and Hematological Variables in Rats 🌺
  • Evaluation of the antiplasmodial and cytotoxicity potentials of husk fiber extracts from Cocos nucifera 🥥
  • Hepatoprotective effect of the aqueous extract of leaves of Acalypha racemosa in carbon tetrachloride treated rats 🌱
  • Toxicological studies and antimicrobial properties of some Iron (III) complexes of Ciprofloxacin 🧪
  • Activity of ethanolic extract of Clerodendrum violaceum leaves against Plasmodium berghei in mice 🐭
  • Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance 🧫
  • Inhibition mechanism of alpha-amylase by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth 💚
  • Morinda lucida Benth (Rubiaceae): A review of its ethnomedicine, phytochemistry and pharmacology 📚

Conclusion

Professor Oluwatosin Adekunle Adaramoye is a highly qualified candidate for the Best Researcher Award based on his extensive research experience, substantial international recognition, and significant contributions to the field of biochemistry. His work on medicinal plants, particularly in areas related to anti-cancer and anti-diabetic effects, combined with his leadership roles and global collaborations, positions him as a distinguished researcher. Addressing the areas for improvement could further bolster his application and showcase the broader impact of his research endeavors.